{
"id":"mk19_a_on_t06",
"number":6,
"bookId":"on",
"title":{
"__html":"Staging and Prognosis of Invasive Breast Cancer"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"076f25",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 6. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_on_t06"
}
]
},
"Staging and Prognosis of Invasive Breast Cancer"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"64c6da",
"class":"col hd l",
"children":[
"Stage"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0b890b",
"class":"col hd l",
"children":[
"Definition"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bc68e9",
"class":"col hd l",
"children":[
"5-Year Relative Survival",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
" Rates"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cfcd20",
"class":"cell txt l",
"children":[
"0"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bcd4c6",
"class":"cell txt l",
"children":[
"Ductal carcinoma in situ (negative lymph nodes)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"30bd7c",
"class":"cell txt l",
"children":[
"100%"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b77c2f",
"class":"cell txt l",
"children":[
"Localized"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e92193",
"class":"cell txt l",
"children":[
"IA: Tumor ≤2 cm and negative lymph nodes"
]
},
" ",
{
"type":"p",
"hlId":"a79bea",
"class":"cell txt l",
"children":[
"IB: Tumor ≤2 cm and 1 to 3 micrometastatic positive lymph nodes (0.2-2 mm)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d0de2f",
"class":"cell txt l",
"children":[
"98.9%"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9c1c67",
"class":"cell txt l",
"children":[
"Regional"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3223dc",
"class":"cell txt l",
"children":[
"IIA: Tumor ≤2 cm with 1 to 3 positive lymph nodes (>2 mm) ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"OR"
]
}
]
},
" ",
{
"type":"p",
"hlId":"2feaf1",
"class":"cell txt l",
"children":[
"Tumor 2-5 cm with negative lymph nodes"
]
},
" ",
{
"type":"p",
"hlId":"069b1b",
"class":"cell txt l",
"children":[
"IIB: Tumor 2-5 cm with 1 to 3 positive lymph nodes ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"OR"
]
}
]
},
" ",
{
"type":"p",
"hlId":"c19111",
"class":"cell txt l",
"children":[
"Tumor >5 cm with negative lymph nodes"
]
},
" ",
{
"type":"p",
"hlId":"d0321d",
"class":"cell txt l",
"children":[
"IIIA: Tumor ≤5 cm with 4 to 9 positive lymph nodes ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"OR"
]
}
]
},
" ",
{
"type":"p",
"hlId":"a21c9b",
"class":"cell txt l",
"children":[
"Tumor >5 cm with 1 to 9 positive lymph nodes"
]
},
" ",
{
"type":"p",
"hlId":"7654e1",
"class":"cell txt l",
"children":[
"IIIB: Tumors with skin or chest wall involvement with 0 to 9 positive lymph nodes"
]
},
" ",
{
"type":"p",
"hlId":"a40d60",
"class":"cell txt l",
"children":[
"IIIC: Tumors with 10 or more positive lymph nodes"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"71e922",
"class":"cell txt l",
"children":[
"85.7%"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0c2277",
"class":"cell txt l",
"children":[
"Distant"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1ca90d",
"class":"cell txt l",
"children":[
"Distant metastatic disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5f29c5",
"class":"cell txt l",
"children":[
"28.1%"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Relative survival is the ratio of the proportion of observed survivors in a cohort of patients with cancer to the proportion of expected survivors in a comparable set of cancer-free individuals."
],
[
"Data from Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2017, National Cancer Institute. Bethesda, MD, ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"https://seer.cancer.gov/csr/1975_2017/",
"target":"_blank"
},
"children":[
"https://seer.cancer.gov/csr/1975_2017/"
]
},
", based on November 2019 SEER data submission, posted to the SEER web site, April 2020. Accessed January 1, 2021."
]
]
}